Imperial Valley News
Washington, DC - For the first time, researchers have used national data to determine the incidence of the four major molecular subtypes of breast cancer by age, race/ethnicity, poverty level, and several other factors. These four subtypes respond differently to treatment and have different survival rates.
Reclamation Releases Final Environmental Documents on Cawelo Water District and North Kern Water Storage District Calloway Canal Lining Project
Sacramento, California - The Bureau of Reclamation has released final environmental documents for a proposed canal lining project that will be partially funded with CALFED Water Use Efficiency Project Grants.
White House Press Secretary on the Global Entrepreneurship Summit and President Obama’s Travel to Africa
Washington, DC - The Government of Kenya has agreed to co-host the 2015 Global Entrepreneurship Summit (GES) this July. Organized annually since 2009, the GES has emerged as a global platform connecting emerging entrepreneurs with leaders from business, international organizations, and governments looking to support them. This will be the first time the GES will take place in sub-Saharan Africa.
Washington, DC - The United States is concerned by reports that the Government of Burma has filed criminal charges against peaceful protesters engaged in campaign activities advocating reform of the National Education Law. We call for the immediate, unconditional release of all individuals being detained in the country as a result of exercising their right to peacefully assemble.
Imperial, California - Bowing your head in prayer is a good thing to do, but be careful not to bow too low. A New Jersey man did just that at a local restaurant over a steak fajita skillet and, boy, did he get burned, reports the Association of Mature American Citizens.
BioMarin Announces One Oral and 7 Poster Presentations at the 2015 American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting
San Rafael, California - BioMarin Pharmaceutical Inc. today announced the results of a post-hoc sub-analysis of the PKU-016 or ASCEND study, the largest randomized controlled trial evaluating neurocognitive outcomes in patients with phenylketonuria (PKU) treated with the approved therapy Kuvan® (sapropterin dihydrochloride)at the 2015 American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting.